Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Recurrent or Persistent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07195734
What this trial is testing

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell Carcinoma+15 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)UnknownNCT02492503
What this trial is testing

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Who this might be right for
Metastatic Carcinoma to the Uterine CervixRecurrent Carcinoma CervixCervix Carcinoma Recurrent
All India Institute of Medical Sciences 40
Testing effectiveness (Phase 2)UnknownNCT04395612
What this trial is testing

Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02257528
What this trial is testing

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Ended earlyNCT05179239
What this trial is testing

SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Who this might be right for
Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 31
Early research (Phase 1)Study completedNCT00003977
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Steward St. Elizabeth's Medical Center of Boston, Inc.